Report by : Gan Yung Chyan, KUCINTA SETIA
News (1)
Special permission to use "antibody cocktail", Fauci inferred it helps Trump recover
After Trump was infected with the epidemic, it was suspected that he was once seriously ill, but his condition is believed to improve rapidly after receiving treatment different from the general public. Fauci, director of the National Institute of Allergy and Infectious Diseases, said on Monday (5th) that he believed that the experimental antibody cocktail therapy REGN-COV2 that Trump received before he was admitted to the hospital helped him resist the worst effects of the virus.
REGN-COV2 therapy combines two "monoclonal antibodies" (antibodies made by only one type of immune cell) to fight the virus. Anthony Fauci, regarded as a general in the fight against the epidemic in the United States, pointed out that scientists are very optimistic about "monoclonal antibodies" as one of the potential treatment options for SARS-CoV-2. He said that Regeneron's monoclonal antibody has been very successful against the highly infectious disease Ebola. It is a very special protein and may be very important in the treatment of patients with the virus. He said that although it is possible that Trump himself reversed his condition, he believes REGN-COV2 will help Trump get better. However, he emphasized that a lot of research is still needed to prove that it is indeed effective.
News (2)
Regeneron shares rise
This therapy has been effective in clinical trials with 275 patients, but it has not been urgently authorized by the U.S. Food and Drug Administration (FDA). Regeneron said they only provided the drugs after receiving a request for "compassionate use" from Dr. Trump. In the United States, if the general public wants to use unapproved drugs through "compassionate use", the process is long and must meet a series of requirements, but Trump, as the national leader, can use it one day after the diagnosis. Trump also used Remdesivir, which has not been approved by the FDA as a treatment for the new coronavirus, but the FDA can authorize emergency use. Trump is familiar with Regeneron's chief executive officer, and the company's stock price has risen 110% in the past year, and it soared by nearly 10% on Monday.
News (3)
Many covid patients in the US suffer from neurological problems and other symptoms
A US researcher published a report on Monday that 82% of covid patients who need to be admitted to hospital have neurological problems, and nearly one-third have brain dysfunction, including mental confusion, confusion, and even coma. Most serious cases involve 65 years of age. Most of the above-mentioned elderly cannot handle daily activities such as cooking and paying bills. The study was conducted from March to April this year and analyzed the medical records of 509 patients in 10 hospitals in the Chicago area.
Sources : CNN/ABC/NBC
No comments:
Post a Comment